{"id":71444,"date":"2025-09-18T10:21:51","date_gmt":"2025-09-18T10:21:51","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/"},"modified":"2025-09-18T10:21:51","modified_gmt":"2025-09-18T10:21:51","slug":"transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/","title":{"rendered":"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-d7ef9e1999cc4a231e1b26ae13093fa0 wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-4bcda2f4287742f0d046360c0adb98de wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-a8743fdddeaaf3f7044f07803f61fbcc wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-aa44f537e9d07279d6c2e4ae1e48577c wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-1d7dbd56da82402cae1493096fe68fce wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-cd711a22e86802b6dfcecbe8da41a8d5 wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-3a3b65fa9f9059f6c8e393679d76ab54 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-bb62116f00123f1a7cdc6686bd580a1d wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-24e111758f38141d8db728162845d6c3 wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-6561c211ae9f4a0ea2aaff89ae468649 wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-43e004e0f476036ef172bb51229d34ae wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">Risk visibility in the pharmaceutical industry is a critical concern due to the inherent complexities and high-stakes nature of drug development and manufacturing. The pressures around risk visibility arise from multiple factors, including regulatory requirements, competition, financial implications, and potential impacts on patient safety.<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies must adhere to stringent regulations set forth by bodies like the FDA, EMA, and other global health authorities. These regulations require transparency in operations and demand rigorous risk management processes. Inadequate risk visibility can lead to compliance issues, resulting in fines, product recalls, or even shutdowns.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Reputation and Trust: A lack of effective risk management can lead to publicized failures, damaging a company's reputation and eroding stakeholder trust. In the age of social media and instant communication, the fallout from a risk event can spread rapidly, making damage control exceedingly difficult and costly.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Financial Consequences: An undisclosed or poorly managed risk can have severe financial implications. For instance, delays in product launch due to unforeseen risks can result in significant revenue loss. Furthermore, addressing a crisis post-factum often involves massive expenses in terms of legal counsel, crisis management, and reparative measures.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Patient Safety and Ethics: At the core, the pharmaceutical industry is about safeguarding human health. Risks that are not adequately visible or managed can compromise patient safety, which is both an ethical issue and a direct threat to the viability of a company if harmful incidents occur.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Competitive Pressures: With numerous companies vying for market share, the ability to swiftly respond to and manage risks can determine a company's competitive edge. Those who fail to do so may find themselves losing ground to more agile and risk-aware competitors.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying Risk of Inaction<\/p><p class=\"tekst-para wp-block-paragraph\">The cost of inaction in managing risks can be substantial:<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Penalties and Fines: Non-compliance penalties vary but can range from thousands to millions of dollars per incident, depending on the severity and jurisdiction.<\/p><p class=\"tekst-para wp-block-paragraph\">- Legal Costs and Settlements: Pharmaceutical litigation can result in multimillion-dollar settlements, not to mention the ongoing legal fees.<\/p><p class=\"tekst-para wp-block-paragraph\">- Loss of Product Approval: If a product's risks are not adequately controlled, there may be delays or retractions in regulatory approval, translating to a direct loss of potentially billions in revenue.<\/p><p class=\"tekst-para wp-block-paragraph\">- Stock Price Volatility: Public risk incidents can lead to stock price drops, affecting market valuation and investor confidence.<\/p><p class=\"tekst-para wp-block-paragraph\">Implementing Strong Risk Management Practices<\/p><p class=\"tekst-para wp-block-paragraph\">Fostering robust risk visibility doesn't necessarily depend on specific software but rather on having a comprehensive risk management framework in place that may include:<\/p><p class=\"tekst-para wp-block-paragraph\">- Cross-functional Collaboration: Encouraging departments like R&D, manufacturing, and compliance to work together to identify and mitigate risks.<\/p><p class=\"tekst-para wp-block-paragraph\">- Continuous Monitoring and Reporting: Establishing protocols for ongoing risk evaluation and clear communications to all stakeholders.<\/p><p class=\"tekst-para wp-block-paragraph\">- Scenario Planning and Simulations: Running drills and hypothetical scenarios to prepare for potential risk events.<\/p><p class=\"tekst-para wp-block-paragraph\">An example of a tool that can facilitate enhanced risk visibility is a collaboration platform like KanBo, which assists organizations in structuring communication and project oversight. This can aid in centralizing risk data and ensuring it is accessible and actionable by all necessary parties, thereby improving the overall risk management effort. However, the choice of tools should align with a company\u2019s specific needs and processes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, risk visibility for a Compliance Manager handling issues and complaints is critical. It ensures that potential compliance violations and quality-related issues are identified, addressed, and mitigated promptly to maintain regulatory standards and public safety. Let's define some key terms relevant to this context and see how KanBo can enhance risk visibility using its features:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker: In the context of handling compliance issues and complaints, a card blocker could be an unresolved issue, missing documentation, or an incomplete investigation that halts progress. Differentiating between local, global, and on-demand blockers enables the Compliance Manager to categorize and prioritize obstacles effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict: Date conflicts can arise when overlapping timelines for different compliance tasks cause resource allocation or scheduling issues. For example, investigating multiple complaints simultaneously without enough personnel or time can impact efficiency.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relation: Card relation helps in managing complex compliance tasks by breaking them down into more manageable parts. Understanding dependencies between tasks ensures that necessary prerequisites are met before proceeding, reducing risks of oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notification: Notifications keep the Compliance Manager and relevant team members informed of any updates or changes in status regarding a compliance issue. This ensures timely responses and action plans, crucial in a regulated field.<\/p><p class=\"tekst-para wp-block-paragraph\"> KanBo's Role in Enhancing Risk Visibility<\/p><p class=\"tekst-para wp-block-paragraph\"> Visible Blockers<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo allows Compliance Managers to mark any issues or tasks as blockers, visibly flagging them in the system. By identifying and categorizing blockers as local, global, or on-demand, managers gain a clear view of which obstacles affect the team or project as a whole versus those specific to individual tasks.<\/p><p class=\"tekst-para wp-block-paragraph\"> Mapped Dependencies<\/p><p class=\"tekst-para wp-block-paragraph\">Using card relations, KanBo helps in mapping out task dependencies so that Compliance Managers can visually track which investigations or actions depend on others. This mapping prevents date conflicts and ensures a logical progression from investigation initiation to resolution.<\/p><p class=\"tekst-para wp-block-paragraph\"> Notifications<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's notification system provides timely updates related to the status of tasks and compliance issues. When a blocker is resolved, dependencies are updated, or comments are added, notifications alert interested parties, ensuring no critical updates are missed.<\/p><p class=\"tekst-para wp-block-paragraph\">By integrating KanBo's features into the compliance workflow, risk visibility is significantly enhanced. Compliance Managers can swiftly identify and address potential risks, avoid scheduling conflicts, and maintain an up-to-date overview of all ongoing compliance tasks. This proactive approach ensures regulatory standards are met consistently and efficiently.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\">Case Study: Enhancing Risk Visibility in Pharmaceutical Compliance Management with KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">Background:<\/p><p class=\"tekst-para wp-block-paragraph\">In the fast-paced and highly regulated environment of pharmaceuticals, Compliance Managers handling issues and complaints face numerous challenges in ensuring risks are visible and managed effectively. Traditionally, risk management has relied on paper trails and disparate digital systems, leading to inefficiencies such as delays in reporting, missed deadlines, and overlooked compliance violations. These obstacles can significantly impact a company's ability to maintain regulatory compliance and uphold patient safety standards.<\/p><p class=\"tekst-para wp-block-paragraph\">Scenario:<\/p><p class=\"tekst-para wp-block-paragraph\">Dr. Anna Peterson, the Compliance Manager at PharmaSafe Inc., is responsible for handling issues and complaints related to drug safety and quality. Her team is tasked with investigating reported incidents, addressing compliance gaps, and ensuring timely reporting to regulatory bodies. However, using outdated methods, such as Excel spreadsheets and email chains, has introduced several challenges:<\/p><p class=\"tekst-para wp-block-paragraph\">- Delays: Due to lack of real-time updates, investigation processes are delayed as Anna must manually track the status of each complaint across multiple systems.<\/p><p class=\"tekst-para wp-block-paragraph\">- Inefficiencies: Overlapping investigation schedules are common, causing resource allocation conflicts and making it difficult for Anna to prioritize tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">- Risks: Poor visibility of dependencies between tasks leads to missed critical steps in the compliance workflow, increasing the risk of non-compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">Challenge:<\/p><p class=\"tekst-para wp-block-paragraph\">Anna needs a solution to improve risk visibility and management efficiency. She seeks to ensure her team can promptly respond to complaints, reduce the likelihood of compliance breaches, and enhance overall project success.<\/p><p class=\"tekst-para wp-block-paragraph\">Solution with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blockers: <\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo allows Anna to mark unresolved issues, such as missing documentation, as blockers in the system. By differentiating them as local or global blockers, Anna can quickly identify which problems need immediate attention and allocate resources efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflicts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Using KanBo's card relation features, Anna can easily map dependencies between tasks and avoid scheduling conflicts. By visualizing the order and timeline of investigations, the team prevents overlapping investigations and ensures all tasks are completed in sequence.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relations:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Complex compliance tasks are broken down into smaller, manageable parts using KanBo's parent-child card relations. This ensures all prerequisite steps are completed before moving forward, reducing the risk of oversight and non-compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's notification system keeps Anna and her team informed of any updates or changes in the status of compliance issues. This proactive approach ensures timely responses and adjustments, critical in maintaining regulatory compliance and responding to auditors.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">By integrating KanBo into her workflow, Anna has transformed how her team manages compliance issues and complaints. The visibility provided by card blockers and date conflict mapping has minimized delays and resource conflicts, while card relations have reduced the risk of oversight. Notifications ensure that all team members remain informed and responsive to changes.<\/p><p class=\"tekst-para wp-block-paragraph\">As a result, PharmaSafe Inc. has seen improved compliance rates, reduced risk of fines, enhanced operational efficiency, and maintained their reputation as a trusted pharmaceutical provider. The proactive risk management facilitated by KanBo contributes significantly to the overall success of their compliance and risk management projects, ensuring continuous adherence to regulatory standards and maintaining patient safety.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, particularly for Compliance Managers handling issues and complaints, traditional tools and methods often lack the agility and clarity needed for effective risk management and compliance adherence. KanBo offers a modern alternative, enhancing risk visibility and streamlining the compliance workflow. Here's how KanBo's features replace outdated methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker: <\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Paper trails and spreadsheets are often used to track unresolved issues, leading to delays and oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: With the Card Blocker feature, Compliance Managers can instantly mark unresolved issues, missing documentation, or incomplete investigations. This digital flagging system allows for swift identification and classification of blockers as local, global, or on-demand, facilitating prioritized action.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Manual scheduling with calendars or Excel sheets often misses overlapping timelines, causing resource allocation issues.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: KanBo's Mapped Dependencies feature prevents date conflicts by enabling visual tracking of task dependencies. This ensures that tasks are completed in the correct order and resources are allocated efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relation:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Isolated task lists or basic project management tools only track individual tasks, leading to lack of coordination.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Card Relations in KanBo allow tasks to be linked, creating a clear workflow. This enhances understanding of task relationships and dependencies, reducing the risk of oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notification:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Reliance on email chains or phone calls for updates diminishes effective communication and can result in missed information.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: With Notifications, KanBo keeps all relevant parties informed about updates, status changes, or comments on compliance tasks. This ensures that responses are timely and no critical updates are missed.<\/p><p class=\"tekst-para wp-block-paragraph\"> Enhancements with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\"> Visible Blockers<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo provides a centralized digital platform where all blockers are visible and easily categorized, eliminating the inefficiencies of paper-based tracking or scattered digital files.<\/p><p class=\"tekst-para wp-block-paragraph\"> Mapped Dependencies<\/p><p class=\"tekst-para wp-block-paragraph\">By mapping task dependencies visually, KanBo prevents scheduling conflicts, ensuring that Compliance Managers have a clear view of task sequences and prerequisites.<\/p><p class=\"tekst-para wp-block-paragraph\"> Notifications<\/p><p class=\"tekst-para wp-block-paragraph\">Consistent notifications ensure that all stakeholders remain informed about task progress and changes, facilitating proactive compliance management.<\/p><p class=\"tekst-para wp-block-paragraph\">By replacing older, less efficient tools with KanBo's dynamic features, Compliance Managers in pharmaceuticals can ensure more effective risk management and compliance with regulatory standards, ultimately enhancing public safety and operational efficiency.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the realm of Risk Visibility for Compliance Manager Issues and Complaints in the Pharmaceutical sector, certain elements will remain unchanged despite technological advancements. Leadership judgment, strategy ownership, and accountability continue to rest with humans. These aspects involve complex decision-making and ethical considerations, which technology can only amplify, not replace. The constant is a human-first approach, where technologies support but do not override human insight and responsibility.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">Who did what and when?  <\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's tracking capabilities allow Compliance Managers to easily document and access records of who handled specific tasks, what actions were taken, and the exact timeline of events, ensuring full accountability and traceability in compliance processes.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path?  <\/p><p class=\"tekst-para wp-block-paragraph\">Critical path threats often include unresolved card blockers, inadequate resources for simultaneous investigations, or overdue tasks due to mismanaged dependencies and priorities.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks?  <\/p><p class=\"tekst-para wp-block-paragraph\">Bottlenecks are typically found in areas with insufficient resource allocation, unresolved issues noted as card blockers, or overlapping tasks without clear progression plans.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why?  <\/p><p class=\"tekst-para wp-block-paragraph\">Tasks may be overdue due to unresolved dependencies, lack of timely notifications and updates, or inefficient allocation of personnel to high-priority compliance issues. KanBo\u2019s task tracking helps in identifying and addressing these delays promptly.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">- 23% Impact: Studies have shown that improving risk visibility can reduce compliance breaches by up to 23%, showcasing its importance in maintaining regulatory standards in the pharmaceutical sector. <\/p><p class=\"tekst-para wp-block-paragraph\">- $100 Million Penalties: Major pharmaceutical companies have faced regulatory fines exceeding $100 million due to compliance breaches and inadequate risk management, underscoring the financial stakes involved.<\/p><p class=\"tekst-para wp-block-paragraph\">- 80% Time Savings: Implementing effective risk visibility tools can lead to an 80% reduction in the time taken to resolve compliance issues and complaints, enhancing operational efficiency.<\/p><p class=\"tekst-para wp-block-paragraph\">- 70% Stakeholder Trust: Companies with robust risk management frameworks report up to a 70% increase in stakeholder trust and investor confidence, highlighting the reputational benefits.<\/p><p class=\"tekst-para wp-block-paragraph\">- 5-10% Revenue Loss: Pharmaceutical firms can lose between 5-10% of their annual revenue due to unmanaged risks and compliance failures, which can be mitigated through improved risk visibility.<\/p><p class=\"tekst-para wp-block-paragraph\">- $2.5 Billion Impact: Failure to appropriately manage risk and compliance issues can delay product approvals or launches, potentially resulting in lost revenues exceeding $2.5 billion per product.<\/p><p class=\"tekst-para wp-block-paragraph\">- 50% Reduction in Complaints: Effective risk management frameworks and tools lead to a 50% reduction in compliance-related complaints from regulatory bodies, improving overall company compliance ratings.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What impact does inadequate risk visibility have on regulatory compliance in pharmaceuticals?<\/p><p class=\"tekst-para wp-block-paragraph\">   Inadequate risk visibility can lead to compliance issues such as fines, product recalls, or even shutdowns, as pharmaceutical companies must adhere to stringent regulations from health authorities like the FDA and EMA.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How can lack of effective risk management affect a pharmaceutical company\u2019s reputation?<\/p><p class=\"tekst-para wp-block-paragraph\">   Without effective risk management, publicized failures can damage a company's reputation and erode stakeholder trust, especially with the rapid spread of information via social media.<\/p><p class=\"tekst-para wp-block-paragraph\">3. What are the financial consequences of undisclosed or poorly managed risks in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   Poorly managed risks can lead to revenue loss due to delayed product launches, alongside massive costs for crisis management, legal counsel, and reparative measures.<\/p><p class=\"tekst-para wp-block-paragraph\">4. How are patient safety and ethics compromised by inadequate risk management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Inadequate risk management can compromise patient safety, posing ethical challenges and threatening a company\u2019s viability if harmful incidents occur.<\/p><p class=\"tekst-para wp-block-paragraph\">5. What role does competitive pressure play in pharmaceutical risk management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Competitive pressure demands swift risk management to maintain a competitive edge. Companies that fail in this aspect may lose market share to more agile competitors.<\/p><p class=\"tekst-para wp-block-paragraph\">6. How does KanBo enhance risk visibility for Compliance Managers in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo enhances risk visibility by providing tools like card blockers, mapped dependencies, and notifications, allowing Compliance Managers to track and manage compliance issues efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">7. How can KanBo help prevent scheduling conflicts and ensure compliance tasks are completed efficiently?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo manages task dependencies and provides real-time notifications, which help prevent scheduling conflicts and ensure that compliance tasks proceed logically and efficiently.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">Below is a plain text table representing the key issues and complaints that a Compliance Manager might face in the Pharmaceutical industry. This table is structured around the problems identified and the related KanBo features that can assist in managing these issues effectively:<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Issue\/Complaint         | Description                                          | KanBo Feature                                  |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance | Ensuring adherence to FDA, EMA, etc.               | Visible Blockers: Categorize unresolved issues |<\/p><p class=\"tekst-para wp-block-paragraph\">|                         |                                                      | Notifications: Update on status changes        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Reputation and Trust | Managing public perception and stakeholder trust    | Mapped Dependencies: Track tasks with impact   |<\/p><p class=\"tekst-para wp-block-paragraph\">|                         | after an issue is reported                           | Notifications: Timely updates on resolutions   |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Consequences| Preventing revenue loss and unexpected costs       | Visible Blockers: Prioritize high-impact risks |<\/p><p class=\"tekst-para wp-block-paragraph\">|                         | due to compliance failures                          | Mapped Dependencies: Analyze financial impact  |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Patient Safety and Ethics | Safeguarding health against risks              | Visible Blockers: Identify safety-related issues|<\/p><p class=\"tekst-para wp-block-paragraph\">|                              |                                                  | Notifications: Critical safety alerts          |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Competitive Pressures | Staying ahead of competitors by managing risks    | Mapped Dependencies: Prioritize competitive edges|<\/p><p class=\"tekst-para wp-block-paragraph\">|                          | efficiently                                         | Visible Blockers: Quick resolution path        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Date Conflict        | Resource allocation issues during task overlap      | Mapped Dependencies: Visual task sequence      |<\/p><p class=\"tekst-para wp-block-paragraph\">|                         |                                                      | Notifications: Alert on conflicts              |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Card Relation       | Handling complex tasks by tracking dependencies      | Mapped Dependencies: Manage task relationships |<\/p><p class=\"tekst-para wp-block-paragraph\">|                         |                                                      |                                                |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------------+------------------------------------------------------+------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table consolidates the various compliance-related issues a Compliance Manager may encounter, linking them with relevant features in KanBo that can enhance visibility and facilitate effective risk management.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve Risk Visibility issues for a Compliance Manager dealing with pharmaceutical complaints, consider implementing a multi-faceted approach encompassing robust software solutions and procedural enhancements:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Centralized Digital Platform: Implement a centralized digital platform (e.g., SafeQual, MasterControl) that provides a unified view of compliance issues and complaints. This platform should support real-time tracking, documentation, and analytics, allowing the Compliance Manager to quickly identify and assess potential risks.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Automated Alerts and Dashboards: Utilize automated alerts to notify the Compliance Manager and relevant stakeholders of any new complaints or anomalies detected in ongoing processes. Dashboards should provide real-time data visualization to help prioritize issues based on risk level.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Risk Assessment Protocols: Standardize risk assessment protocols that include regular audits and compliance checks. This ensures that all complaints and potential non-compliance issues are evaluated consistently and thoroughly.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Cross-departmental Communication: Enhance communication between departments such as Quality Assurance, Regulatory Affairs, and Legal. Regular inter-departmental meetings can ensure that relevant insights and risk assessments are shared promptly.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Training and Education: Regularly train employees on compliance standards and risk management strategies. This enhances the organization\u2019s ability to preemptively recognize and report potential compliance issues.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Root Cause Analysis Tools: Integrate root cause analysis tools to aid in identifying underlying issues of complaints, helping to prevent recurrence and improve overall compliance processes.<\/p><p class=\"tekst-para wp-block-paragraph\">By combining a digital platform with strong procedural frameworks and effective communication, a Compliance Manager can significantly improve risk visibility and ensure timely action against potential compliance threats.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"MainConcepts\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"RiskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Description\": \"Critical for drug development and manufacturing due to high-stakes and complexity.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Factors\": [\"Regulatory Compliance\", \"Reputation\", \"Financial Consequences\", \"Patient Safety\", \"Competitive Pressures\"]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KeyAspects\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"RegulatoryCompliance\": \"Adherence to FDA, EMA, and global regulations; failure leads to fines and product recalls.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"ReputationAndTrust\": \"Failures can damage reputation and stakeholder trust, especially with rapid information spread.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"FinancialConsequences\": \"Poor risk management leads to revenue loss and crisis expenses.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"PatientSafetyAndEthics\": \"Central to the industry; unmanaged risks threaten health and company viability.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"CompetitivePressures\": \"Risk management is vital for maintaining market position.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"CostsOfInaction\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"RegulatoryPenalties\": \"Thousands to millions per incident.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"LegalCosts\": \"Multimillion-dollar settlements plus legal fees.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"LossOfProductApproval\": \"Delays or retractions lead to revenue losses.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"StockPriceVolatility\": \"Public incidents can harm stock prices.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"RiskManagementPractices\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Strategies\": [\"Cross-functional Collaboration\", \"Continuous Monitoring\", \"Scenario Planning\"],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Tools\": \"Platforms like KanBo assist in risk data centralization.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"KanBoFeatures\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"VisibleBlockers\": \"Identifies and categorizes task blockers in compliance management.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"MappedDependencies\": \"Tracks task dependencies to avoid date conflicts.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Notifications\": \"Provides updates on task status changes.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"ImprovementWithKanBo\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Goal\": \"Enhance risk visibility and compliance workflow.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Outcome\": \"Swift risk identification and resolution, adherence to standards.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71444","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\\\/\",\"name\":\"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:21:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/","og_locale":"en_US","og_type":"article","og_title":"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/","name":"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:21:51+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-risk-visibility-for-compliance-managers-navigating-regulatory-challenges-and-seizing-opportunities-in-the-pharmaceutical-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Transforming Risk Visibility for Compliance Managers: Navigating Regulatory Challenges and Seizing Opportunities in the Pharmaceutical Industry"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71444"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71444\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}